Antimicrobial Dispensing Practice in Community Pharmacies in Russia during the COVID-19 Pandemic.
Creators
- 1. Internal Medicine Department #2, First Moscow State Medical University, 119991 Moscow, Russia.
- 2. Institute of Antimicrobial Chemotherapy, Smolensk State Medical University, 214019 Smolensk, Russia.
- 3. Department of Internal Medicine and General Medical Practice, North-Eastern Federal University, 677007 Yakutsk, Russia.
- 4. Department of Clinical Pharmacology and Drug Ethics, UNESCO, Yaroslavl State Medical University, 150000 Yaroslavl, Russia.
- 5. Department of Pharmacology, Saratov State Medical University n.a. V.I. Razumovsky, 410012 Saratov, Russia.
- 6. Department of Pharmacology and Propedeutics of Internal Diseases, First Moscow State Medical University, 119991 Moscow, Russia.
Description
COVID-19 has had a significant impact on health care systems, including drug use. The present study aimed to evaluate the patterns of community supply of antimicrobials from community pharmacies during the COVID-19 pandemic in five cities of Russia. In a cross-sectional study, a random sample of pharmacies reported all episodes of antimicrobials supply during a one-week period. Patterns of supply (age and gender of customer, drug name and formulation, prescription availability, indication, etc.) were analyzed. Altogether, 71 pharmacies took part in the study and 5270 encounters were recorded. In total, 4.2% of visits resulted in supply of more than one antimicrobial agent and 5.2% were for parenteral formulations. The rate of prescription-based purchase in participated cities varied from 40.5 to 99.1%. Systemic antibiotics and antivirals accounted for the majority of supplies (60.5 and 26.3%, respectively). Upper respiratory tract infections were reported as the indication for antimicrobials usage in 36.9% of cases, followed by skin and soft tissue infections (12.1%) and urinary tract infections (8.7%); COVID-19 accounted for 8.4% of all supplies. Amoxicillin with clavulanic acid, azithromycin and amoxicillin were indicated as the top three antimicrobials purchased for upper respiratory tract infections, and azithromycin, umifenovir and levofloxacin were the top three for COVID-19. In general, a high rate of drugs dispensing without prescription was revealed. Antibiotics for systemic use remained the most common antimicrobials, whereas presumably viral upper respiratory tract infections were the main reason for their purchase. COVID-19 infection itself was responsible for a small proportion of the supply of antimicrobial agents, but systemic antibiotics accounted for more than a half of supplies.
Open Access
Licence Attribution (CC BY)
Publisher Website
Access full text
Publication Details
Journal article
Persistent Identifiers
Funding
Financial Support
WHO Regional Office for Europe
Read more
References
Sulis, G., Batomen, B., Kotwani, A., Pai, M., and Gandra, S. (2021). Sales of an...
Read more
Chedid . Antibiotics in treatment of COVID-19 complications: A review of frequen...
Read more
Goff . Global contributions of pharmacists during the COVID-19 pandemic, J. Am. ...
Read more
Kaae . The antibiotic knowledge, attitudes and behaviors of patients, doctors an...
Read more
Belkina, T., Duvanova, N., Karbovskaja, J., Tebbens, J.D., and Vlcek, J. (2017)....
Read more
Showing first 5 of 21 references.